Adeyinka Gladys Falusi

Suggest Changes
Learn More
The majority of clinical trials of neo-adjuvant therapy for breast cancer have been conducted in resource-rich countries. We chose Nigeria, a resource-poor country, as the major site for a phase II(More)
  • 1